Clinical Trial Update: This Study Aims to Find a Safe and Effective Dose of BI 754091. The Study Also Aims to Find Safe and Effective Doses of BI 754091 and BI 754111 in Combination. This Study is Done in Asian Patients With Different Types of Cancer [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial evaluated safe dosing of BI 754091 alone and in combination with BI 754111 in Asian patients with various cancers; results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• BI-754091
• BI-754111

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-12-19